Scientific priorities and real prospects for cost optimization in formulation development

• Published in: Entrepreneurship and Sustainability Issues Vol. 7; no. 3; pp. 1484 - 1499
• Main Authors: Glembotskaya, Galina T., Eremin, Stanislav Yu, Chupandina, Elena E.
• Format: Journal Article
• Language: English
• Published: Vilnius Entrepreneurship and Sustainability Center 01.03.2020
• Subjects: Pharmaceutical industry; Trends
• ISSN: 2345-0282; 2345-0282
• DOI: 10.9770/jesi.2020.7.3(4)

As a result of the systematic structural analysis of the collected scientific data on the problem under study, the trends in the development of the pharmaceutical sector that have established in the global space, including the Russian Federation, have been marked, the changes in the modern healthcare systems have been noted, and it has been proven that the problem of finding accelerated and efficient methods of drug development that meet the interests of all stakeholders needs the priority solution. The structure of distributing the clinical studies of drugs in the world practice has been presented, and data on the funds for the development of the main stages of the process under study and therapeutic groups of drugs for various nosologies have been presented. The main difficulties of objective assessment of the formulation development costs have been defined, the influencing factors have been identified, and the methodical approach to calculating the resources spent has been proposed. The results have been summarized, and the prospects for the rational use of the advanced information technologies for the development and support of innovative domestic developments in the pharmaceutical sector have been demonstrated. As a result of the research into the scientific data, a real opportunity to optimize the costs of developing innovative drugs through their repositioning has been demonstrated for the first time, the conceptual methodical approach to solving the identified problems has been justified, and prospects for its implementation have been outlined, with due consideration for the further development of the pharmaceutical market and the introduction of personalized pharmaceutical care. The study has been conducted on the basis of systematic analytical structuring of the information data and the results of independent research with the identification of global trends and the determination of practical significance, as well as scientific perspectives in the field under study.